Latest From Getinge AB
Major medical device companies paid almost $1bn in consulting fees, royalties, research costs and other expenses to physicians in 2017, the most recent data release from the US Open Payments database shows. Zimmer Biomet reported the highest spending on general physician payments, while Roche and Medtronic topped the list of research spending.
Venus Medtech, the Chinese transcatheter aortic valve technology specialist, has made its second international acquisition as it pursues its strategy for global expansion in the TAVR market.
Getinge is looking for a new CEO after deciding to jettison Alex Myers from the helm, less than 18 months after he took up the top executive role.
Hemovent GMBH has developed a miniaturized extracorporeal membrane oxygenation system for bedside use in intensive care. The start-up says the footprint of its ECMO is just 10% the size of the smallest commercially available heart-lung machine, and the cost of the unit is 95% less than a standard ECMO device.
- Implantable Devices
- Infection Control-Sterilization
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Getinge Medical Systems
- Western Europe
- Parent & Subsidiaries
- Getinge AB
- Senior Management
Johan Malmquist, Pres. & CEO
Ulf Grunander, CFO
Michael Rieder, EVP, Sales & Mktg.
- Contact Info
Phone: (46) 10 335 0000
P.O. Box 8861 Göteborg, NY SE-402 72
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.